Entries of Uharek, L. on the publication server

Neuenhahn, M., Albrecht, J., Odendahl, M., Schlott, F., Dössinger, G., Schiemann, M., Lakshmipathi, S., Martin, K., Bunjes, D., Harsdorf, S., Weissinger, E. M., Menzel, H., Verbeek, M., Uharek, L., Kröger, N., Wagner, E., Kobbe, G., Schroeder, T., Schmitt, M., Held, G., Herr, W., Germeroth, L., Bonig, H., Tonn, T., Einsele, H., Busch, D. H. and Grigoleit, G. U. (2017) Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT. Leukemia 31 (10), pp. 2161-2171. Fulltext not available.

Schmidt-Hieber, M., Blau, I. W., Trenschel, R., Andreesen, Reinhard, Stuhler, G., Einsele, H., Kanz, L., Keilholz, U., Marinets, O., Beelen, D. W., Fauser, A. A., Volin, L. , Ruutu, T., Uharek, L., Fietz, T., Knauf, W., Hopfenmüller, W., Thiel, E., Freund, M. and Casper, J. (2007) Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma. Bone marrow transplantation 39 (7), pp. 389-96. Fulltext not available.

Wolff, D., Wilhelm, S., Hahn, J., Gentilini, C., Hilgendorf, I. , Steiner, B., Kahl, C., Junghanss, C., Hartung, G., Casper, J., Uharek, L., Holler, E. and Freund, M. (2006) Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease. Bone Marrow Transplantation 38 (6), pp. 445-451. Fulltext not available.